Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 340

Similar articles for PubMed (Select 19343511)

1.

The epidemiology of triple-negative breast cancer, including race.

Trivers KF, Lund MJ, Porter PL, Liff JM, Flagg EW, Coates RJ, Eley JW.

Cancer Causes Control. 2009 Sep;20(7):1071-82. doi: 10.1007/s10552-009-9331-1. Epub 2009 Apr 3.

PMID:
19343511
2.

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.

Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O'Regan RM, Gabram SG, Eley JW.

Breast Cancer Res Treat. 2009 Jan;113(2):357-70. doi: 10.1007/s10549-008-9926-3. Epub 2008 Mar 7.

PMID:
18324472
3.
4.
5.

A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China.

Xing P, Li J, Jin F.

Med Oncol. 2010 Sep;27(3):926-31. doi: 10.1007/s12032-009-9308-7. Epub 2009 Sep 23.

PMID:
19771534
7.

Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.

Clarke CA, Keegan TH, Yang J, Press DJ, Kurian AW, Patel AH, Lacey JV Jr.

J Natl Cancer Inst. 2012 Jul 18;104(14):1094-101. doi: 10.1093/jnci/djs264. Epub 2012 Jul 5.

8.

Age/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes: a population-based study and first report.

Lund MJ, Butler EN, Hair BY, Ward KC, Andrews JH, Oprea-Ilies G, Bayakly AR, O'Regan RM, Vertino PM, Eley JW.

Cancer. 2010 Jun 1;116(11):2549-59. doi: 10.1002/cncr.25016.

11.

Obesity and risk of the less commonly diagnosed subtypes of breast cancer.

Stark A, Schultz D, Kapke A, Nadkarni P, Burke M, Linden M, Raju U.

Eur J Surg Oncol. 2009 Sep;35(9):928-35. doi: 10.1016/j.ejso.2008.11.009. Epub 2009 Jan 1.

PMID:
19121564
12.

Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.

Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.

J Surg Res. 2007 Nov;143(1):109-18.

PMID:
17950079
13.

Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer.

Ma H, Luo J, Press MF, Wang Y, Bernstein L, Ursin G.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):479-85. doi: 10.1158/1055-9965.EPI-08-0805. Epub 2009 Feb 3.

14.

Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups.

Kurian AW, Fish K, Shema SJ, Clarke CA.

Breast Cancer Res. 2010;12(6):R99. doi: 10.1186/bcr2780. Epub 2010 Nov 19.

15.

Hormone receptor status of breast tumors in black, Hispanic, and non-Hispanic white women. An analysis of 13,239 cases.

Gapstur SM, Dupuis J, Gann P, Collila S, Winchester DP.

Cancer. 1996 Apr 15;77(8):1465-71.

PMID:
8608530
16.

Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age.

Britton JA, Gammon MD, Schoenberg JB, Stanford JL, Coates RJ, Swanson CA, Potischman N, Malone KE, Brogan DJ, Daling JR, Brinton LA.

Am J Epidemiol. 2002 Sep 15;156(6):507-16.

17.

High prevalence of triple-negative tumors in an urban cancer center.

Lund MJ, Butler EN, Bumpers HL, Okoli J, Rizzo M, Hatchett N, Green VL, Brawley OW, Oprea-Ilies GM, Gabram SG.

Cancer. 2008 Aug 1;113(3):608-15. doi: 10.1002/cncr.23569.

18.

Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.

Ferguson NL, Bell J, Heidel R, Lee S, Vanmeter S, Duncan L, Munsey B, Panella T, Orucevic A.

Breast J. 2013 Jan-Feb;19(1):22-30. doi: 10.1111/tbj.12059. Epub 2012 Dec 13.

PMID:
23240985
19.

Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival.

Onitilo AA, Engel JM, Greenlee RT, Mukesh BN.

Clin Med Res. 2009 Jun;7(1-2):4-13. doi: 10.3121/cmr.2009.825.

20.

Risk factors for hormone receptor-defined breast cancer in postmenopausal women.

Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2482-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk